Future development of the biotechnology industry in Australia and overseas hinge on the availability of high purity proteins in relatively large quantities. Efficient purification processes are needed for this to be achieved. This project explores a new way to make and use novel chromatographic materials with properties that permit high resolution and purity to be obtained and which allow current constraints associated with the capture and purification of recombinant proteins to be overcome. As a consequence, this project could lead to a considerable advance in the manufacture of recombinant proteins destined for industrial, diagnostic, therapeutic or other types of application.
|Effective start/end date||1/07/09 → 31/12/13|
- Australian Research Council (ARC): AUD671,580.00
- Australian Research Council (ARC): AUD78,420.00
- Novo Nordisk Pharmaceuticals Pty Ltd: AUD691,851.00